<DOC>
	<DOCNO>NCT01709331</DOCNO>
	<brief_summary>This study ass corifollitropin alfa ( MK-8962 ) , administer combination human chorionic gonadotropin ( hCG ) , increase testicular volume men HH remain azoospermic treatment hCG alone . Hypothesis : The low limit 95 % confidence interval geometric mean increase testicular volume Day 1 Week 52 great one .</brief_summary>
	<brief_title>A Study Efficacy Safety Corifollitropin Alfa ( MK-8962 ) Combination With Human Chorionic Gonadotropin ( hCG ) Adult Men With Hypogonadotropic Hypogonadism ( HH ) ( P07937 )</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Diagnosed hypogonadotropic hypogonadism , either congenital acquire Have low circulating level testosterone Have low circulating level gonadotropin ( follicle stimulate hormone [ FSH ] ; luteinizing hormone ) Presence scrotal testis Have azoospermia ( measurable level sperm ) Adequate replacement pituitary hormone Good general physical mental health Primary hypogonadism , Klinefelter 's syndrome History unilateral bilateral cryptorchidism ( maldescended testis ) History presence testicular pathology clinical importance ( e.g. , epididymitis , orchitis , testicular torsion , varicocele stage III , testicular atrophy , occlusive azoospermia , etc ) , and/or vasectomy Treated FSH , hCG gonadotropinreleasing hormone ( GnRH ) within previous 3 month 1 month within previous 6 month Proven spermatogenesis hCG treatment alone Previous unsuccessful attempt hCG combination human menopausal gonadotropin ( hMG ) /FSH achieve spermatogenesis Required dose hCG 6000 international unit ( IU ) per week previous attempt normalize T level Untreated pituitary hypothalamic tumor , inadequately treat pituitary hypothalamic tumor likely progress study History presence ( know suspect ) testicular , prostatic breast cancer Prostate pathology clinical importance Past present oncologic treatment ( chemo/radiotherapy ) Diabetes mellitus Clinically significant , untreated hyperprolactinaemia Uncontrolled nongonadal endocrinopathies ( thyroid , adrenal , pituitary disorder ) Tested positive Human Immunodeficiency Virus ( HIV ) , Hepatitis B Hepatitis C User recreational illicit drug recent history ( within past year ) drug abuse dependence , increase alcohol consumption Allergy/sensitivity gonadotropins its/their excipients Has receive within previous 1 month plan use : Hormonal preparation study medication , drug know impair testicular function , agent know affect sex hormone secretion and/or drug know suspect teratogenic Used investigational drug within three month actively participate another study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>